Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 67862
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
67862
Date of registration
08.02.2021
Company name
Eli Lilly (Suisse) SA
Revision date
Valid until
19.12.2029
Indication
Date of market entry
Index Therapeuticus (BSV)
07.16.10.
Revocation Date
Index Therapeuticus (Swissmedic)
07.16.10.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Retsevmo 40 mg
gélules
Capsules ( 40 mg)
L01EX22
CI
02
Retsevmo 80 mg
gélules
Capsules ( 80 mg)
L01EX22
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
